Page 1 of 1

2023-Yamauchi et al-preprint

PostPosted: Wed Mar 15, 2023 3:20 pm
by mleipold
"Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma"
Masami Yamauchi, Atsushi Ono, Kei Amioka, Yasutoshi Fujii, Hikaru Nakahara, Yuji Teraoka, Shinsuke Uchikawa, Hatsue Fujino, Takashi Nakahara, Eisuke Murakami, Wataru Okamoto, Daiki Miki, Tomokazu Kawaoka, Masataka Tsuge, Michio Imamura, Nelson Hayes, Waka Ohishi, Takeshi Kishi, Mizuki Kimura, Natsumi Suzuki, Koji Arihiro, Hiroshi Aikata, Kazuaki Chayama, Shiro Oka
Res Sq, posted 08 Mar, 2023
https://doi.org/10.21203/rs.3.rs-2586140/v1

- will update when/if this is peer-reviewed and published

- no dataset accession given

Re: 2023-Yamauchi et al-preprint

PostPosted: Mon Nov 06, 2023 8:21 pm
by mleipold
Now published:

Commun Med. 2023, 3, 152
https://doi.org/10.1038/s43856-023-00390-x

- "The datasets generated during the current study are available in the Figshare repository: https://doi.org/10.6084/m9.figshare.22215760.v3"